DENTSPLY SIRONA Inc. Expected to Earn Q1 2025 Earnings of $0.53 Per Share (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Analysts at William Blair issued their Q1 2025 earnings estimates for shares of DENTSPLY SIRONA in a research report issued on Thursday, May 2nd. William Blair analyst B. Vazquez anticipates that the medical instruments supplier will post earnings per share of $0.53 for the quarter. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $2.04 per share. William Blair also issued estimates for DENTSPLY SIRONA’s Q2 2025 earnings at $0.59 EPS, Q3 2025 earnings at $0.59 EPS, Q4 2025 earnings at $0.64 EPS and FY2025 earnings at $2.35 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.42. The business had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.39 earnings per share.

XRAY has been the topic of several other research reports. Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. SVB Leerink assumed coverage on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. They set an “outperform” rating and a $42.00 target price on the stock. The Goldman Sachs Group reduced their target price on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating for the company in a research report on Monday. Robert W. Baird decreased their price target on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a research note on Friday, May 3rd. Finally, Evercore ISI dropped their price objective on shares of DENTSPLY SIRONA from $40.00 to $35.00 and set an “outperform” rating for the company in a research note on Friday, May 3rd. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $35.22.

DENTSPLY SIRONA Stock Performance

XRAY stock opened at $28.25 on Monday. DENTSPLY SIRONA has a 12-month low of $26.27 and a 12-month high of $41.65. The business’s 50-day moving average is $31.91 and its 200 day moving average is $32.66. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. The stock has a market cap of $5.87 billion, a price-to-earnings ratio of -64.20, a PEG ratio of 1.24 and a beta of 1.00.

DENTSPLY SIRONA Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 2.27%. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date was Wednesday, March 27th. DENTSPLY SIRONA’s dividend payout ratio is presently -145.45%.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of hedge funds have recently modified their holdings of the business. Parkside Financial Bank & Trust lifted its stake in DENTSPLY SIRONA by 33.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after acquiring an additional 292 shares in the last quarter. Beach Investment Counsel Inc. PA boosted its stake in shares of DENTSPLY SIRONA by 1.4% in the fourth quarter. Beach Investment Counsel Inc. PA now owns 22,125 shares of the medical instruments supplier’s stock valued at $787,000 after purchasing an additional 306 shares during the period. Wahed Invest LLC grew its holdings in shares of DENTSPLY SIRONA by 9.3% in the fourth quarter. Wahed Invest LLC now owns 3,603 shares of the medical instruments supplier’s stock valued at $128,000 after purchasing an additional 306 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. lifted its holdings in DENTSPLY SIRONA by 5.4% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 6,950 shares of the medical instruments supplier’s stock worth $237,000 after buying an additional 359 shares in the last quarter. Finally, VisionPoint Advisory Group LLC boosted its position in DENTSPLY SIRONA by 104.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock valued at $26,000 after buying an additional 395 shares during the period. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.